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Background: Several animal models have been established to investigate the mechanisms of obliterative
bronchiolitis after lung transplantation. In this study, we compared three prevalent murine models of
obliterative bronchiolitis in terms of several basic pathologic changes in a relatively short span of time
after transplantation.
Methods: Each of the recipient mice simultaneously received orthotopic, intra-omental and subcutaneous
tracheal transplantation in both syngeneic and allogeneic settings. No immunosuppressive treatment was
administered. Tracheal grafts were harvested on Day 14, 21 and 28 after transplantation for histological
and immunohistochemical analyses.
Results: Syngeneic tracheal grafts from different transplant sites retained normal histologic structures, while
their corresponding allografts demonstrated more occlusion of the airway lumen as well as more inﬁltration
of CD4+/CD8+ mononuclear cells and myoﬁbroblasts, but less regenerative epithelium and neovascularized
vessels at indicated times (P b 0.05). Compared with two heterotopic allografts, orthotopic allografts had less
occlusion of the tracheal lumen as well as less inﬁltration of CD4+/CD8+mononuclear cells and myoﬁbroblasts,
but more regenerative epithelium and neovascularized vessels (P b 0.05).
Conclusions: Orthotopic tracheal transplantation in mice can be considered as a model to study early stages of
obliterative bronchiolitis, and heterotopic tracheal transplantation can be a model for late stages of obliterative
bronchiolitis.© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-SA license.1. Introduction
Lung transplantation becomes the only available therapeutic option
for patients with selected end-stage pulmonary diseases. Despite that
great improvements have been achieved, the long-term survival of
patients with pulmonary allografts is still barely satisfactory, which
continues to be hampered by obliterative bronchiolitis (OB) and its
clinical correlate, bronchiolitis obliterans syndrome (BOS). BOS was
reported in 49% of patients by 5 years after transplantation and in 75%
by 10 years, on the basis of data including more than 13,000 recipientsnchiolitis obliterans syndrome;
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.V.Open access under CC BY-NC-SA licwho survived at least 14 days [1]. OB is an inﬂammatory and
ﬁbroproliferative disorder affecting small airways of the transplanted
lung and has been generally considered as a form of chronic rejection.
Increasing clinical studies have indicated risk factors related to the de-
velopment of OB [2]. However, the speciﬁc pathogenesis of OB remains
unclear, and further research is necessary to elucidate the underlying
pathogenic mechanisms.
Rodents, with the advantage of easy manipulation over a short-time
frame, play an important role inOB research. As an experimental animal
in transplantationmodels, the rat has been highly recommended in the
past [3,4]. The mouse, however, would be a much more valuable tool
owing to the widespread use of genetically deﬁned inbred and
engineered strains, and commercial availability of various reagents.
The orthotopic lung transplant in mice might be best mimicking the
clinical surgery, but has the drawbacks of technical difﬁculty and low
level of reproducibility of OB lesions [5,6]. Therefore it has been gener-
ally used to study early postoperative problems, such as ischemia-
reperfusion and acute rejection. In 1993, Hertz and colleagues
implanted tracheal grafts into a subcutaneous pouch of the neck of
recipient mice, and successfully induced typical OB lesions [7]. After-
wards, several transplantation models of a trachea in variable sitesense.
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modiﬁcations and variants [11,12] were developed by the other investi-
gators. Although the distributions of cartilage rings and submucosal
glands in mice trachea are like those in human small airways [13],
somemay argue that differencesmay exist in themechanisms that con-
tribute to the tracheal obliteration in this model as compared to the
bronchiole obliteration in human transplant lungs. Moreover, different
groups were inclined to investigate diverse issues through their pre-
ferredmodels, but all themodels failed to perfectly elucidate themech-
anism of OB. So in this situation, investigators were confused to choose
the appropriate model for their hypothesis or speciﬁc question.
In this study we combined orthotopic, intra-omental and subcuta-
neous tracheal transplantation, which have been well-established
and reproducible OB models [9,10,14], to investigate several basic
pathologic changes during the post-transplant period. Each donor tra-
chea was divided into three segments and then respectively im-
planted into three sites of each corresponding recipient. Finally, the
morphological changes of the grafts on various days after transplanta-
tion were analyzed and compared.
2. Materials and methods
2.1. Animals
Speciﬁc pathogen-free, female C57BL/6 (H-2b) mice and Balb/C
(H-2d) mice (Jackson Laboratory) weighing 20–24 g were used. All an-
imals were housed in the speciﬁc pathogen-free facility (Tongji Medical
College, Huazhong University of Science and Technology, Wuhan,
China) and had access to water and food ad libitum. All the studies
were performed in compliancewith the Principles of Laboratory animal
care (NIH publication Vol 25, No. 28 revised 1996) and the Tongji Med-
ical College Animal Care and Use Committee Guidelines.
Tracheas from Balb/c mice were implanted into Balb/c mice (synge-
neic, n = 45) or C57BL/6mice (allogeneic, n = 45). Each donor tracheal
graft was evenly divided into three segments, and then simultaneously
implanted into orthotopic, intra-omental and subcutaneous sites of
each recipient. Grafts (15 syngeneic or 15 allogeneic grafts from each
transplant site) were harvested on Days 14, 21 and 28 after transplanta-
tion for histologic and immunohistologic analyses.
2.2. Donor procedure
The donors were euthanized by intraperitoneally injecting pento-
barbital (80 mg/kg). A midline cervical incision was performed to ex-
pose the entire trachea. The trachea below the cricoid cartilage distal
to the bifurcation was dissected, harvested, and then it was ﬂushed
and preserved with cold sterile saline at 4 °C. Prior to implantation,
the full-length trachea (approximately 12 cartilage rings) was divided
into three segments of 4 cartilage rings, which were then randomly
transplanted into various sites respectively.
2.3. Recipient procedure
The recipients were anesthetized by intraperitoneally injecting
pentobarbital (50 mg/kg). Initially, a short midline cervical incision
was performed to visualize the entire laryngotracheal complex. The
recipient trachea was carefully dissected, and then transected at the
third intercartilage below the epiglottis while spontaneous breathing
was maintained. One of the 4-ring donor tracheal segments was im-
planted end-to-end, starting with the distal anastomosis using 9-0
Prolene suture (Ethicon). The cervical incision was closed in layers
with continuous 7-0 Vicryl suture (Ethicon). Subsequently, the recip-
ient mouse underwent a midline laparotomy followed by exposure of
the greater omentum. The second tracheal segment was wrapped and
ﬁxed into the greater omentum using 9-0 Prolene, and then the ab-
dominal wall was closed in layers with continuous 7-0 Vicryl suture.Finally, a small incision was made in the dorsal suprascapular area
of the recipient mice. A subcutaneous pouch was made with blunt
dissection, and then the third tracheal segment was placed into it.
The skin was closed with interrupted 7-0 Vicryl suture. The operative
procedures were performed with the assistance of a surgical micro-
scope (×10 magniﬁcation) in a sterile fashion. All recipient animals
received no immunosuppression.
2.4. Histology and immunohistochemistry
The grafts were harvested from CO2 euthanized recipient mice on
Day 14, 21, and 28 after transplantation for histologic and immuno-
histochemical analyses. Tracheal grafts were cut into longitudinal sec-
tions for hematoxylin and eosin (H&E) or immunohistochemical
staining. Each graft segment for H&E staining was ﬁxed in 4% formalin
at room temperature for 24 h. The formalin-ﬁxed tissues were em-
bedded in parafﬁn, later cut into 4-μm sections and then stained
with H&E.
For immunohistochemistry studies, 5-μm routine sections were
used. CD4 and CD8 positive cells were respectively identiﬁed by
mouse monoclonal anti-CD4 and anti-CD8 (BD Biosciences). Vessel
endothelial cells were identiﬁed by mouse monoclonal anti-CD31
(BD Biosciences). For ﬁbroproliferative tissue staining, mouse mono-
clonal anti-actin, α-smooth muscle (α-SMA, Sigma-Aldrich) was
used. For each primary antibody, an appropriate irrelevant IgG was
used as negative control to ensure that effects of nonspeciﬁc binding
were recognized.
2.5. Morphologic studies
A microscope (BX51, Olympus) with camera (AxioCam MRc, Carl
Zeiss) and Image-Pro Plus 6.0 for Windows (Media Cybernetics) anal-
ysis program were used for morphometric analysis, which were
performed by two independent, blinded reviewers. All measurements
were performed on six random sections from each graft. Lumenal oc-
clusion was deﬁned as the area containing tissue inside of the carti-
lage ring. The percentage of luminal occlusion was calculated as
follows: (area within cartilage-area within residual lumen) / area
within cartilage × 100%. Mucus, produced by airway epithelial cells,
in the lumen was not calculated as obliteration. The histologic
changes in respiratory epithelium were evaluated as percentage of
lumenal circumference covered by ciliated epithelium. CD4+/CD8+
mononuclear cells were quantiﬁed as the total number of positively
stained, mononuclear cells in the lamina propria of the graft in each
selected section. CD31+ blood vessels were counted in same fashion
with CD4+/CD8+ cells. The percentage of α-SMA positive area inside
of the cartilage ring was calculated in the same fashion as lumenal
occlusion.
2.6. Statistical analysis
All data are presented as mean ± SEM. GraphPad Prism 5 for Win-
dows (GraphPad Software, Inc.) was used for statistical analysis.
One-way repeated measures analysis of variance (ANOVA) followed
by Tukey's test or Friedman test followed by Dunn's test (nonparamet-
ric) was used within a group. Comparisons between syngeneic
grafts and allografts were performed using t-test or Mann–Whitney
test (nonparametric). P b 0.05 was regarded as statistically signiﬁcant.
3. Results
3.1. Histological assessment
The syngeneic grafts basically retained normal tracheal architecture with lumenal pa-
tency and no aberrant granulation tissue found (Fig. 1A–C, G–I, M–O). Among the synge-
neic grafts, their percentages of lumenal occlusion were around 20% which were close to
the normal trachea (Fig. 2A), and signiﬁcantly different among various transplant sites
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subcutaneous grafts (P b 0.05), which demonstrated more patent than orthotopic grafts
(P b 0.05). Among allografts, the percentages of lumenal occlusion were signiﬁcantly dif-
ferent (P = 0.0067. Fig. 2A): the tracheal lumen of orthotopic allografts progressively oc-
cluded (Fig. 1D–F), and the percentage of lumenal obliteration exceeded 40% on Day 28;
heterotopic allografts exhibited typical histological changes of OB with complete occlu-
sion occurred by Day 28 (Fig. 1J–L, P–R), and tracheal lumen of heterotopic allografts
was more occlusive than orthotopic allografts (P b 0.05), while lumenal occlusion of
two different heterotopic allografts was not signiﬁcantly different (P > 0.05). Compared
with the corresponding syngeneic grafts, airway lumen of allografts demonstrated to be
more occlusive at various time points (P b 0.05 respectively).
Syngeneic grafts after transplantation maintained normal or nearly normal ciliated
mucosa (Fig. 1A–C, G–I, M–O inset): pseudostratiﬁed ciliated epithelium with glands
lined almost the entire tracheal lumen, and the secretory function was restored.
Among syngeneic grafts, the levels of epithelization were signiﬁcantly different
(P = 0.0022) (Fig. 2B): orthotopic syngeneic grafts covered less ciliated epithelium
than heterotopic syngeneic grafts (P b 0.05); the two heterotopic grafts were not sig-
niﬁcantly different (P > 0.05). Allografts progressively lost epithelium, and levels of
remaining ciliated epithelium were signiﬁcantly different (P = 0.0025): orthotopic al-
lografts underwent squamous metaplasia and ulceration in varying degrees (Fig. 1D–F
inset), and had higher level of epithelization than the heterotopic allografts (P b 0.05)
(Fig. 2B); in heterotopic allografts, the tracheal mucosa underwent progressive degrees
of denudation, and ﬁnally lost nearly all of the epithelium and basement membrane
(Fig. 1J–L, P–R inset), and the level of epithelization of two heterotopic allografts was
not signiﬁcantly different (P > 0.05) (Fig. 2B). Compared with their corresponding
syngeneic grafts, allografts regenerated lower level of epithelium at various times
following transplantation (P b 0.05) (Fig. 2B).3.2. Immunohistochemical assessment
There were mild inﬁltrations of CD4+/CD8+ mononuclear cells in syngeneic grafts,
which were not signiﬁcantly different among various transplant sites (P = 0.1944).
Compared with syngeneic grafts, more severe inﬁltration of CD4+/CD8+ mononuclear
cells was detected in allografts during the observation period (P b 0.05 respectively)
(Fig. 3A, B). Inﬁltrations of CD4+/CD8+ mononuclear cells in allografts were signiﬁ-
cantly different (P = 0.0003): orthotopic allografts demonstrated a continual increase
in cellular inﬁltration over time; heterotopic allografts demonstrated cellular inﬁltrate,
peaked on Day 21 (intra-omental allografts, CD4+/CD8+: 160 ± 13/184 ± 24; subcu-
taneous allografts, CD4+/CD8+: 164 ± 11/175 ± 17) and sustained high level on Day
28 (intra-omental allografts, CD4+/CD8+: 154 ± 15/177 ± 14; subcutaneous allo-
grafts, CD4+/CD8+: 160 ± 14/161 ± 15), which were more than orthotopic allografts
(P b 0.05) but were not signiﬁcantly different between two heterotopic allografts
(P > 0.05) (Fig. 3E).Fig. 1. Histological features of syngeneic grafts and allografts on D 14, 21 and 28 after transp
Syngeneic grafts wrapped in greater omentum on D 14 (G), 21 (H) and 28 (I) post-transp
Orthotopic allografts on D 14 (D), 21 (E), and 28 (F) post-transplant. Allografts wrapped in g
on D 14 (P), 21 (Q), and 28 (R) after transplantation (H&E; original magniﬁcation: ×100; iCD31, a vascular cell-speciﬁc cell–cell adhesion molecule, has been identiﬁed to
play an important part in the process of angiogenesis. We stained CD31 to investigate
the angiogenesis ability in different transplant sites (Fig. 3C). The quantities of CD31+
blood vessels in various syngeneic grafts were signiﬁcantly different (P = 0.0002):
intra-omental syngeneic grafts had more CD31+ blood vessels than subcutaneous syn-
geneic grafts (P b 0.05), which had more than orthotopic syngeneic grafts (P b 0.05).
The quantities of CD31+ blood vessels in various allografts were also signiﬁcantly dif-
ferent (P = 0.0093): the quantity of CD31+ blood vessels in orthotopic allografts was
more than heterotopic allografts (P b 0.05), while the quantities were not signiﬁcantly
different between two heterotopic allografts (P > 0.05). Compared with the corre-
sponding syngeneic grafts, all of the allografts had revascularization at lower level
(P b 0.05) (Fig. 4A).
Myoﬁbroblasts with capacity of collagen synthesis are involved in tissue remodel-
ing. We used α-SMA as a marker for myoﬁbroblasts to determine the ﬁbrosis degrees
in transplanted trachea (Fig. 3D). In syngeneic grafts, myoﬁbroproliferation was nearly
undetectable during the observation time, whereas allografts had more proliferation of
myoﬁbroblasts in lamina propria of transplanted trachea (P b 0.05). The percentages of
α-SMA positive area were not signiﬁcantly different in syngeneic grafts (P = 0.5278).
The percentages were signiﬁcantly different in allografts (P = 0.0030): The percent-
ages of α-SMA+ area in two different heterotopic allografts were similar (P > 0.05),
but signiﬁcantly higher than orthotopic allografts (P b 0.05) (Fig. 4B).4. Discussion
The optimal tool to study OB pathogenesis, no doubt, is human
lung transplantation. However, drawbacks such as sparse OB samples,
and difﬁculties of sampling at various times, in addition to complica-
tions after sampling like infections, hamper human lung transplanta-
tion to act as a “model”. There is therefore a critical need for some
animal models that could elucidate the pathogenesis of OB.
Of the different tracheal transplantation models employed in this
study, each has obvious advantages and drawbacks [15], and previous
investigators have not yet come to a consistent conclusion on which
of the transplantation models is more qualiﬁed as a model for study-
ing OB. Since evidence is mounting that epithelial damage [16,17],
immune-mediated tissue injury [18], angiogenesis [19,20] and
ﬁbroproliferative remodeling [21] may be involved in the develop-
ment of OB, we compared transplantation models in terms of these
hotspot issues in this study. In addition, we combined transplantationlantation. Orthotopic syngeneic grafts on D 14 (A), 21 (B), and 28 (C) post-transplant.
lant. Subcutaneous syngeneic grafts on D 14 (M), 21 (N) and 28 (O) post-transplant.
reater omentum on D 14 (J), 21 (K), and 28 (L) post-transplant. Subcutaneous allografts
nset magniﬁcation: ×400).
Fig. 2. A, Quantitive analysis of lumenal obliteration of tracheal grafts. B, Quantitive analysis of percentage of tracheal lumen covered by ciliated epithelium. Data are expressed as
mean ± SEM.
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prove individual error and the experimental efﬁciency.
In human, the development of BOS is rare within the ﬁrst year
after lung transplant, but the cumulative incidence ranges from 43
to 80% within the ﬁrst ﬁve years of transplantation [22]. Histological-
ly, early lesions of BOS demonstrate submucosal lymphocytic inﬂam-
mation and disruption of the epithelium of small airways, followed by
a buildup of granulation tissue in the airway lumen, resulting in par-
tial obstruction. Subsequently, granulation tissue organizes in aFig. 3. A, Immunohistochemical staining of CD4+ cells from orthotopic allograft on D 21 po
allograft on D 21 post transplantation. C, Immunohistochemical staining of CD31+ blood ves
staining of α-SMA+ from intra-omental allograft on D 21 post transplantation. Original ma
cell inﬁltration in tracheal grafts. Data are expressed as mean ± SEM.cicatricial pattern with resultant ﬁbrosis and eventually completely
obliterates the airway lumen [23]. It is difﬁcult to deﬁne the distinct
stages of OB development, but each stage has different main patho-
logical features.
Our results demonstrate that orthotopic tracheal allografts were
partially obstructed, in which the mucosa underwent denudation and
squamous metaplasia as well as re-epithelization to various degrees,
while the submucosa had few myoﬁbroblasts but rising number of
inﬂammatory cells. On the other hand, heterotopic allografts werest transplantation. B, Immunohistochemical staining of CD8+ cells from subcutaneous
sels from intra-omental allograft on D 21 post transplantation. D, Immunohistochemical
gniﬁcation: ×400 (A–C); ×100 (D). E, Quantitive analysis of CD4+/CD8+ mononuclear
Fig. 4. A, Quantitive analysis of CD31+ vessels in tracheal grafts. B, Quantitive analysis of α-SMA positive area in tracheal grafts. Data are expressed as mean ± SEM.
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chea had barely epithelium but abundant inﬂammatory cells and
myoﬁbroblasts. Therefore, pathological changes found in orthotopic
and heterotopic allografts are respectively similar to those in different
stages of BOS development in patients who received lung transplant.
Both orthotopic and heterotopic tracheal grafts are nonvascularized
grafts, and there is no supply of blood to the grafts other than from an-
giogenesis, which is passively derived from surrounding tissue during
the course of wound healing after transplantation. Although our study
conﬁrmed that the angiogenesis ability among various transplant sites
was different, all the orthotopic syngeneic grafts basically retained nor-
mal histological structures. We speculate that transplant site would not
be a major factor affecting the development of OB. In lung transplanted
patients, OB is preceded by a decrease in microvascular supply to the
small airways. This ischemic event may lead to airway damage or in-
crease the tendency of scar tissue formation as a repair mechanism.
The small airways then appear to respond to this insult by angiogenesis
[24,25]. Compared with orthotopic allografts, heterotopic allografts
formed lesions with less neovascularized vessels but more ﬁbrous tis-
sues like those in themoremature stage of scar formation. Hence, path-
ological changes in orthotopic and heterotopic allografts may represent
the different stages of OB development: those of orthotopic allografts
exhibit the early stage of OB development while heterotopic allografts
exhibit the advanced stage, but the general trend of lesion development
was identical.
20 years after the implementation of the ﬁrst OB research model [7],
the question is “what is the ideal model of OB.” First, this model is time
and cost saving: it is not practical to spend over months waiting for the
development of OB lesions, while some models are limited in their
high cost and availability. Second, the results of the model are reliable
and highly reproducible: OB lesions and other pathological changes
concerned should be easily detected and measured. Third, the model is
physiological and clinically relevant: the grafts should be communicated
with ambient air and with adequate blood supply which closely mimics
environment of small airways in human. Fourth, themodel has less tech-
nical difﬁculties: Among all the animal models of OB established now,
the model of orthotopic mouse lung transplantation performed by Fan
et al. [6] does not only reﬂect the full physiology of a transplantedgraft, but also allows for the investigation other factors most affecting
the evolution of OB. Thismodel holds great promise for boosting clinical-
ly relevant research, but complicated operations and need of special
mice strain combinations prevent its widespread adoption. Last but not
least, the animals inmodels are easy to receive therapeutic intervention,
in other words, animals with distinct immunological background have
easy access to genetic or drugmanipulation. Moreover, we should notice
that this “ideal”model should be carefully employed based on the specif-
ic hypothesis or question. Under certain conditions, orthotopic or het-
erotopic tracheal transplantation, “the less-than-ideal models”, can also
be employed to explain some hypothesis, or provide useful evidences
for further exploration of the question.
In conclusion, orthotopic tracheal transplantation in mice can be
considered as a model to study early stages of OB, and heterotopic tra-
cheal transplantation can be a model for late stages of OB. In addition,
our results implicate that the development of OB in intra-omental and
subcutaneous allografts followed a similar time course, we presume
that the two different heterotopic transplantation models can substi-
tute for each other.
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